This page is maintained and edited by John Eon (Editor at World Wide News Flash since January, 2010).
You can contribute to this page by sending an email to [email protected] or by using our contact form below.

Qnexa

July 16, 2010 Angelina Heads To Comic-Con - AOL Hot Searches Send by AOLHotSearches Get your Lara Croft action figures lately: Angelina Jolie is heading to Comic-Con! Plus, the FDA rejects Qnexa, the Obamas head to Bar Harbor, Enrique Iglesias kisses a fan and Carte Goodwin is named to Sen. Byrd's seat. [...] Rating: 1 out of 5 stars Rate up / Rate down Report to moderator

July 16, 2010 Arena Soars 30% On Results Of Obesity Drug Study Send by DailyFinance [...] to be Vivus's (VVUS) day as a US Food and Drug Administration advisory panel is weighing the benefits and safety profile of its weight loss drug, Qnexa. [...] Rating: No stars. Rate up / Rate down Report to moderator

July 16, 2010 Qnexa - New Prescription Diet Pill Posted by John Eon Qnexa is a possible new prescription diet pill that is showing remarkable weight loss properties in clinical testing. Its fate rests in the FDA's decision [...] Rating: No stars. Rate up / Rate down Report to moderator

July 16, 2010 FDA Panel Worries About Psych Effects Of Diet Pill | ONN.tv Send by AP Studies of Qnexa show the drug causes significant weight loss, with most patients losing more than ten percent of their weight. But patients also reported memory and attention lapses and trouble finding words. The Mountain View, Calif., [...] Rating: 1 out of 5 stars Rate up / Rate down Report to moderator

July 16, 2010 Vivus Fat Pill Works Safety A Concern FDA Staff | Penny Stock Picks Posted by John Eon There were also more reports of attention span, memory and language problems as well as of increased heart rate in Qnexa patients, the staff said in documents posted on the FDA's website. The potential for increased body acids was also [...] Rating: 1 out of 5 stars Rate up / Rate down Report to moderator

July 16, 2010 Vivus Diet Pill Qnexa Faces Scrutiny On Psychiatric Side Effects, FDA Says Send by www.bloomberg.com Vivus Inc. s weight-loss pill Qnexa may cause psychiatric and cardiovascular side effects and hasnt been sufficiently tested in pregnant women, according to U.S. regulators weighing whether to clear the treatment for sale. [...] Rating: 2 out of 5 stars Rate up / Rate down Report to moderator

July 16, 2010 Vivus's Qnexa Gets Thumbs Down From Mixed FDA Panel | Www.bullfax.com Send by marketmaker Ruthanne Williams Roussel submits:As many will know by now, an FDA briefing panel July 15 recommended against approval of Vivus' (VVUS) obesity drug candidate Qnexa by a vote of 10 to 6. This was originally announced as a vote of 9 to 7 [...] Rating: 5 out of 5 stars Rate up / Rate down Report to moderator

July 16, 2010 Vivus' New Diet Drug Might Get You Pregnant (Whether You Like It ... Send by Jim Edwards Does Vivus' (VVUS) new weight-loss drug Qnexa make you sexy and pregnant? According to the FDA, whose advisory panel votes on whether the drug should be approved tomorrow, some women got unwanted pregnancies during the drug's testing [...] Rating: 4 out of 5 stars Rate up / Rate down Report to moderator

July 16, 2010 Vivus Inc.?s Weight-loss Drug Onexa Faces FDA Test Posted by John Eon (US News Week) A Food and Drug Administration advisory panel on Thursday will decide whether the advantages of using weight-loss pill, Onexa, outweigh effects of the pill on mental health and heart rate. The final decision on the drug will be made later after taking the panel?s recommendation into c [...] Rating: 5 out of 5 stars Rate up / Rate down Report to moderator

July 16, 2010 FDA Panel Rejects Vivus Obesity Pill Qnexa | Gaithersburg.Net Posted by John Eon GAITHERSBURG, Md. An FDA panel Thursday said the risks of fetal exposure, increased heart rate, depression and other problems outweighed the benefits of weight loss for Vivus Inc.'s Qnexa (phentermine/topiramate). [...] Rating: 1 out of 5 stars Rate up / Rate down Report to moderator

July 16, 2010 Vivus Weight-Loss Drug Qnexa Rejected Send by Ryan B. The Food and Drug Administration advised that there was not enough data to offset concerns that Vivus Inc's new prescription weight loss pill Qnexa was safe enough. The pill has been rumored to cause depression, memory-loss, [...] Rating: 2 out of 5 stars Rate up / Rate down Report to moderator

July 16, 2010 FDA Panel To Weigh In On Weight-loss Pill - Health ... Posted by John Eon Patients taking Qnexa saw between 3 and 9 percent weight loss over placebo depending on how much of the drug they took, the staff said. They also benefited from improved blood [...] Rating: 2 out of 5 stars Rate up / Rate down Report to moderator

July 16, 2010 BREAKING NEWS: Panel Not Convinced By Vivus' Qnexa Posted by John Eon GAITHERSBURG, MD -- Expressing the need for more information--especially about teratogenicity--an FDA expert panel has recommended against approval of Vivus' ( NASDAQ: VVUS) obesity drug Qnexa. The vote was six in favor and ten against, with many of the no voters citing the need for more safety data [...] Rating: 1 out of 5 stars Rate up / Rate down Report to moderator

July 16, 2010 Biopharma Report: Vivus Investors Flee To Arena Pharmaceuticals Send by Jason Chew Vivus shares tanked after an expert panel voted 10 to 6 against approving its obesity drug, Qnexa. The panel was particularly worried that Vivus only had one year data for its drug- not long enough in its opinion to gather long term [...] Rating: 4 out of 5 stars Rate up / Rate down Report to moderator

---

Submit article

Name:
E-Mail:
Source:
Article:
Please complete all the fields in order to take your article in consideration.